-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Doximity, Lowers Price Target to $24

Benzinga·05/15/2026 15:27:28
Listen to the news
Goldman Sachs analyst David Roman maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $28 to $24.